October 21, 11:00 AM ET / 8:00 AM PT
Webinar: Details provided upon RSVP approval
There are still great disparities around the world for women in cancer diagnosis, treatment and outcomes. Women are also underrepresented at executive levels in pharmaceutical companies creating those treatments.
For Breast Cancer Awareness Month, Force Family Office is hosting an important discussion of equity in women’s health and work that’s being done in both diagnostics and treatment to rectify the issue.
Our panel will include:
- Marissa Fayer, CEO and Founder of HERHealthEQ, a non-profit that’s creating health equity in developing communities around the world. They provide resources women need to detect, prevent, and treat breast cancer and other non-communicable diseases with the right equipment. Their plans will impact the lives of 1 million women by the end of 2025.
- Dr. Stacy W. Blain, co-founder and Chief Science Officer of Concarlo, a women-led biotech company focused on creating new cancer cures. Concarlo is currently developing a new treatment for metastatic breast cancer that has been shown to cause tumor regression and increase survival rates for subjects with drug resistant tumors in small animal testing.
Join our webinar to hear from Ms. Fayer and Dr. Blain and understand what their organizations are doing to bring much needed resources to detect and treat breast cancer and other conditions affecting women.
If you can’t join us, please consider making a gift to HERHealthEQ by visiting their donation page.
All statements and expressions are the sole opinion of the company and are subject to change without notice. The Company is not liable for any investment decisions by its readers or subscribers. It is strongly recommended that any purchase or sale decision be discussed with a financial advisor, or a broker-dealer, or a member of any financial regulatory bodies. The information contained herein has been provided as an information service only. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. Investors are cautioned that they may lose all or a portion of their investment in this or any other company. Information contained herein contains “forward looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities and Exchange Act of 1934, as amended. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical facts and may be “forward looking statements”. Forward looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of words such as “expects”, “will”, “anticipates”, “estimates”, “believes”, or by statements indicating certain actions “may”, “could”, “should” or “might” occur.